Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
22 hedge funds and large institutions have $2.4M invested in Intellipharmaceuticals International Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 8 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
40% more capital invested
Capital invested by funds: $1.72M → $2.4M (+$683K)
19% less funds holding
Funds holding: 27 → 22 (-5)
28% less call options, than puts
Call options by funds: $605K | Put options by funds: $845K
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
First Foundation Advisors
Irvine,
California
|
+$448K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$365K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$274K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$52.6K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$35.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$119K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$74K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$44.9K |
| 4 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$33.1K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| – | -$2.01K | -78 | Closed |
|
27
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$103 | -4 | Closed |
|
28
Bank of America
Charlotte,
North Carolina
| – | +$26 | +1 | +100% |
|
IPCI Hedge Fund Activity: Q1 2017 in Review
22 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q1 2017, worth a combined $2.4M — up 40% from $1.72M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IPCI and 3 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 9 added.
The largest buyer was First Foundation Advisors, adding an estimated $448K. The largest seller was Susquehanna International Group, cutting an estimated $119K.
- 22 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q1 2017, down from 27 in Q4 2016.
- Funds reported $2.4M of Intellipharmaceuticals International Inc. stock for Q1 2017, up 40% quarter-over-quarter.
- 3 funds opened new Intellipharmaceuticals International Inc. positions in Q1 2017 and 8 closed out, a net change of -5 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q1 2017 was First Foundation Advisors, an estimated $448K added.
- The largest Intellipharmaceuticals International Inc. seller in Q1 2017 was Susquehanna International Group, an estimated $119K sold.
Based on aggregated 13F filings for Q1 2017.